Literature DB >> 21040745

A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.

Meir Goldsmith1, Ala Daka, Nadia F Lamour, Roi Mashiach, Yifat Glucksam, Michael M Meijler, Charles E Chalfant, Tsaffrir Zor.   

Abstract

Prostaglandin E(2) (PGE(2)) is an important mediator of the inflammatory response. Phospho-ceramide analogue-1 (PCERA-1), a synthetic phospholipid-like molecule, was previously reported to modulate pro- and anti-inflammatory cytokine production. We show here that PCERA-1 inhibited LPS-stimulated PGE(2) production in RAW264.7 macrophages, without affecting COX-2 expression. Furthermore, PCERA-1 efficiently suppressed arachidonic acid (AA) release in response to LPS. The dephosphorylated derivative of PCERA-1, ceramide analogue-1 (CERA-1), mimicked the inhibitory effect of PCERA-1 on AA release and PGE(2) production in macrophages. Inhibition of PGE(2) production by CERA-1 was completely rescued by addition of exogenous AA. Importantly, PCERA-1 and ceramide-1-phosphate (C1P) stimulated the enzymatic activity of cPLA(2)α in an in vitro assay, whereas CERA-1 and ceramide inhibited both basal and C1P-stimulated cPLA(2)α activity. Collectively, these results indicate that CERA-1 suppresses AA release and subsequent PGE(2) production in LPS-stimulated macrophages by direct interaction with cPLA(2), and suggest that ceramide may similarly counteract C1P effect on cPLA(2) activity in cells. The suppression of PGE(2) production is suggested to contribute to the anti-inflammatory action of PCERA-1. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21040745      PMCID: PMC3026855          DOI: 10.1016/j.imlet.2010.10.014

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  45 in total

Review 1.  Prostaglandins and cancer.

Authors:  D Wang; R N Dubois
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

Review 2.  The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease.

Authors:  Kazuyuki Noguchi; Isao Ishikawa
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

Review 3.  Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.

Authors:  D Pereg; M Lishner
Journal:  J Intern Med       Date:  2005-08       Impact factor: 8.989

4.  Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function.

Authors:  Yan Cheng; Miao Wang; Ying Yu; John Lawson; Colin D Funk; Garret A Fitzgerald
Journal:  J Clin Invest       Date:  2006-04-13       Impact factor: 14.808

5.  Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo.

Authors:  Tatsuya Hoshino; Tadashi Nakaya; Takashi Homan; Ken-ichiro Tanaka; Yukihiko Sugimoto; Wataru Araki; Masami Narita; Shuh Narumiya; Toshiharu Suzuki; Tohru Mizushima
Journal:  J Biol Chem       Date:  2007-09-02       Impact factor: 5.157

6.  Ceramide 1-phosphate acts as a positive allosteric activator of group IVA cytosolic phospholipase A2 alpha and enhances the interaction of the enzyme with phosphatidylcholine.

Authors:  Preeti Subramanian; Robert V Stahelin; Zdzislaw Szulc; Alicja Bielawska; Wonhwa Cho; Charles E Chalfant
Journal:  J Biol Chem       Date:  2005-03-01       Impact factor: 5.157

7.  Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain.

Authors:  Robert V Stahelin; Preeti Subramanian; Mohsin Vora; Wonhwa Cho; Charles E Chalfant
Journal:  J Biol Chem       Date:  2007-04-30       Impact factor: 5.157

8.  Anionic lipids activate group IVA cytosolic phospholipase A2 via distinct and separate mechanisms.

Authors:  Preeti Subramanian; Mohsin Vora; Luciana B Gentile; Robert V Stahelin; Charles E Chalfant
Journal:  J Lipid Res       Date:  2007-09-21       Impact factor: 5.922

Review 9.  Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases.

Authors:  Jean Y Park; Michael H Pillinger; Steven B Abramson
Journal:  Clin Immunol       Date:  2006-03-15       Impact factor: 3.969

10.  A tale of switched functions: from cyclooxygenase inhibition to M-channel modulation in new diphenylamine derivatives.

Authors:  Asher Peretz; Nurit Degani-Katzav; Maya Talmon; Eyal Danieli; Anna Gopin; Eti Malka; Rachel Nachman; Amiram Raz; Doron Shabat; Bernard Attali
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

View more
  6 in total

1.  Anti-inflammatory effect of acetylpuerarin on eicosanoid signaling pathway in primary rat astrocytes.

Authors:  Yanxiao Xiang; Xinbing Wei; Lin Chen; Huiqing Liu; Xiaoqian Liu; Tian Wang; Xiumei Zhang
Journal:  J Mol Neurosci       Date:  2013-09-13       Impact factor: 3.444

2.  Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages.

Authors:  Mohammad Shoeb; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2011-10-24       Impact factor: 7.376

3.  Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors.

Authors:  Sebastián Katz; Orna Ernst; Dorit Avni; Muhammad Athamna; Amir Philosoph; Lide Arana; Alberto Ouro; L Alexis Hoeferlin; Michael M Meijler; Charles E Chalfant; Antonio Gómez-Muñoz; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2015-12-03       Impact factor: 3.685

4.  Contribution of the platelet activating factor signaling pathway to cerebral microcirculatory dysfunction during experimental sepsis by ExoU producing Pseudomonas aeruginosa.

Authors:  Maria Cristina Plotkowski; Vanessa Estato; Sabrina Alves Santos; Mauricio Costa Alves da Silva; Aline Silva Miranda; Pedro Elias de Miranda; Vanessa Pinho; Eduardo Tibiriça; Verônica Morandi; Mauro Martins Teixeira; Albanita Vianna; Alessandra Mattos Saliba
Journal:  Pathog Dis       Date:  2015-07-17       Impact factor: 3.166

5.  Successful reduction of inflammatory responses and arachidonic acid-cyclooxygenase 2 pathway in human pulmonary artery endothelial cells by silencing adipocyte fatty acid-binding protein.

Authors:  Qian Wang; Guanglin Shi; Ying Teng; Xia Li; Jin Xie; Qin Shen; Caixin Zhang; Songshi Ni; Zhiyuan Tang
Journal:  J Inflamm (Lond)       Date:  2017-03-20       Impact factor: 4.981

Review 6.  The Impact of the Ca2+-Independent Phospholipase A2β (iPLA2β) on Immune Cells.

Authors:  Tayleur D White; Abdulaziz Almutairi; Ying Gai Tusing; Xiaoyong Lei; Sasanka Ramanadham
Journal:  Biomolecules       Date:  2021-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.